Ebos takes 14% stake in Australian medi-softwarefirm MedAdvisor for A$10.5 mln

Ebos Group has branched out into medical software buying a 14 percent stake in Australia's MedAdvisor business for A$10.5 million. 

Christchurch-based Ebos said the investment was part of a wider partnership with the software company, whose system has more than 900,000 users and connects some 2,600 Australian pharmacies.

"Ebos's investment is part of a wider partnership with MedAdvisor that will seek to advance the commercial interests of both organisations by increasing the availability of digital health applications across Ebos's community pharmacy and institutional healthcare businesses," the company said in a statement. 

The healthcare and animal products maker has been expanding its pharmacy footprint, buying Australia’s largest provider of outsourced pharmacy services to hospitals, HPS, for A$154 million, in May. Last year, it bought a majority stake in Terry White Group, merging that business with its Chemmart unit to create one of Australia's largest chains of pharmacies.

Ebos shares slipped 0.2 percent to $17.86, having gained 7.2 percent so far this year. 

(BusinessDesk)

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

NZ dollar falls ahead of inflation data
F&P Healthcare shares hit record on improved guidance
Bounce in international guest nights some reprieve for slowing tourism sector
$4m penalty for Auckland money shop under AML regime
High-emission oil producers at risk from investor action
NZ Rugby gets skin in media game in new Sky broadcasting deal
14th October 2019 Morning Report
US earnings season starts amid glimmers of hope on trade, Brexit
Class action suit against CBL Corp about to launch
NZ dollar benefits from possible US-China trade deal